Health Condition 1: null- Pyriformis syndrome
Conditions
Interventions
Intervention1: Local anaesthetic plus steroids: 3 mL of 0.25% bupivacaine with 40 mg methyl prednisolone will be injected into pyriformis muscle under fluroscopic and nerve stimulator guidance.
Contro
Sponsors
ESI Institute of Pain Management ESI Hospital Sealdah
Eligibility
Inclusion criteria
Inclusion criteria: i. Pain -unilateral hip and/or leg pain with positive FAIR (flexion, adduction, internal rotation) test ii. Tenderness and/or trigger point at the Pyriformis Muscle iii. Pain unresponsive to conservative treatment like pharmacotherapy with nonsteroidal anti-inflammatory drugs, muscle relaxants, and neuropathic pain agents and physical therapy, which includes stretching of the pyriformis Muscle to correct the underlying pathology
Exclusion criteria
Exclusion criteria: i. Uncontrolled hypertension , uncontrolled diabetes mellitus ii. Patients having a neurological deficiency iii. Surgery involving lumbar and/ or hip region iv. History of allergic reaction to the drug and contrast agent to be used v. Patient on anticoagulant vi. History of inflammatory or infectious disease vii. Non-compensated chronic heart/liver/renal deficiency viii. Vascular/tumoral disease. ix. Gestational or lactational period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain using Numerical Rating Score (NRS) on a scale of 1-10Timepoint: Just before the injection and one hour, one week and three weeks after giving the injection | — |
Secondary
| Measure | Time frame |
|---|---|
| Back Disability using the roland morris disability questionnaire on a scale of 0-24.Timepoint: Just before the injection and one hour, one week and three weeks after giving the injection | — |
Countries
India
Contacts
Public ContactDr Subrata Goswami
ESI Institute of Pain Management
Outcome results
None listed